The activity of cefoxitin was compared with that of cephalothin against 229 bacterial strains. Cefoxitin was more active against most Gram-negative strains, notably against indoleproducfng Proteus spp., which are usually resistant to the cephalosporins. Cefoxitin was not susceptible to any significant extent to degradation by f-lactamases produced by Gram-negative organisms. Aga-nst Gram-positive organisms, however, cefoxitin was considerably less active than cephalothin, but minimum inhibitory concentrations for Staphylococcus aureus were well within therapeutically attainable blood leve's.
Introduction
The cephalosporins are superior -to naturally-occurring penicillins in being more stable to staphylococcal f3-lactamases. CE However, cephalosporins are labile to the fl-lactamases of many Gram-negative organisms. A new family of natural products, the cephamycins (Nagarajan et al., 1971; Stapley et al., 1972) , offers hope of overcoming this latter handicap. Early reports indicated that cephamycin C was much less easily degraded by /3-lactamases from members of the enterobacteriaceae than were cephalosporins (Daousit et al., 1973) . As cephamycin C is a close analogue of cephalosporin C, it was only to be expected that chemically-modified semi-synthetic cephamycins would be made, and that these may have superior antimicrobial properties. The first such compound made available for independent investigation was cefoxitin ( fig. 1 ), a compound precisely analogous to cephalothin (Karady et al., 1972) . We have, therefore, studied both the antimicrobial activity and the pharmacokinetics of this compound in comparison with cephalothin, and report the results.
Materials and Methods
Antibiotics.-The sodium salt of cefoxitin and of cephalothin (Keflin) were kindly provided by Dr. C. M. Martin.
Bacterial Strains.-Most of the sttrains used had been freshly isolated in the routine laboratories of this department within the past six months. Eighteen-hour cultures were used, except in the case of Bacteroides fragilis, for which 42-hour cultures in cooked meat medium were used. Determination of Minimum Inhibitory Concentration (M.I.C.).-Serial doubling dilutions of antibiotics were made in Difco brain heart infusion agar, with 4% lysed horse blood added when required. Each plate was streaked with a 10t2 dilution of an 18-hour culture of 10 different strains, and incubated at 37'C for 18 hours (anaerobic organisms were incubated for 42 hours at 37'C with the BBL GasPak system). M.I.C. was taken as the lowest concentration of antibiotic which suppressed growth completely. Antibiotic Destruction.-This was investigated qualitatively by incubating suspensions of washed organisms (concentrated fourfold from 18-hour cultures) with 200 ug/ml of cefoxitin or cephalothin in phosphate-citrate buffer, pH 7, for five hours at 37'C. Residual antibiotic was determined by the microbiological assay described below.
Clinical Pharmacology.-Cefoxitin and cephalothin were given to 18 male human volunteers, aged from 21 to 37 years. Physical examination and laboratory tests before the study did not show evidence of renal, hepatic, cardiopulmonary, haematological, or any other systemic disease. Subjects with a history of allergy to penicillin were excluded. The volunteers were randomly divided into two groups. One group received three injections of cephalothin in weekly intervals, while the other received cefoxitin in the same manner. The three dosages given to each volunteer were: 0-5 g and 1 0 given intramuscularly and 2 0 g given intravenously as a bolus injection lasting three minutes, the order of administration being allocated randomly. Ten serial venepunctures and seven urine collections were made before and up to 12 hours after each intramuscular injection. The schedule was slightly different after intravenous dosage, 11 venepunctures and six urine collections being taken. The precise timings of these 54 profiles are given in ithe Results section. The duration and inten-sity of pain at the site of the injection were recorded. Pain was classified subjectively as follows: 0 = no pain, 1 = mild, 2 = moderate, and 3 = severe pain. Toxicity studies made before and two days after each dose included white blood count, packed cell volume, haemoglobin, platelet count, blood urea, serum aspartate aminotransferase, alkaline phosphatase, total and conjugated bilirubin, as well as urine pH, specific gravity, glucose, protein, and microscopy. All subjects were closely observed over the whole study for the development of side effects.
Antibiotic Assays.-The antibiotic activity of each specimen was estimated by microbiological assay: 100-ml amounts of brain heart infusion agar (Difco) containing 1 ml of an overnight culture of Staphylococcus aureus MB-2786 (kindly supplied by Dr. C. M. Martin) were poured into plastic plates 23-5 cm square. Standards (50, 25, ,ug/ml) and specimens (suitably diluted when necessary) were taken up on to filter paper discs 6 mm in diameter; each disc was found to imbibe 20 ,ul. When assaying sera pooled human plasma was used as diluent, and S0rensen's phosphate buffer, pH 6, was used when urine specimens were assayed. > 500 jxg/ml). Against Gram-positive strains cephalothin was superior by a factor of about tenfold. Nevertheless, the highest M.I.C. for the staphylococcal strains (5 jg/ml for cefoxitin) was considerably less than the peak blood level after the smallest dose (0-5 g) of cefoxitin administered (see below). Anaerobiosis, variation in inoculum size of up to one-millionfold and changes in medium composition and pH (between 5 and 8) had only small effects on the biological activities of both antibiotics.
Susceptibility to B-lactamase Degradation.-All 17 strains belonging to the enterobacteriaceae which were resistant to cefoxitin were tested for their ability to destroy the antibiotic. Pharmacokinetics.-Levels of antibiotic activity in serum after administration of cefoxitin were considerably higher and longer sustained than after cephalothin (table IT) . Biological terminal half life of cephalothin-like activity was 25 minutes, while that of cefoxitin was 45 minutes, as calculated from data in table II. Urine antibiotic activity was also higher in the subjects that received cefoxitin (table III) , though both antibiotics produced very high activity levels in urine. However, in the last urine collections (6-12 hours after in;tramuscular and 4-12 hours after intravenous injection) in 22 (41 %) of the cephalothin profiles the antibiotic activity was below 5 ,ug/ml and in 18 (33%) it was below 2 pg/ml, while in al cefoxitin Acinetobacter spp. These values have been calculated from data given in fig. 2 . Median = Central value. Mode = Single most commonly occurring value. C50 = Concentration of antibiotic which inhibits 50% of the strains (determined graphically). M.I.C. =Minimum inhibitory concentration. The blood levels obtained after administration of cefoxitin were higher and more prolonged than those after cephalothin (table II) , as were the urine levels (table III) , and the terminal serum half life of cefoxitin was almost double that of cephalothin. These latter findings may at least in part be due to the fact that whereas cephalothin is deacetylated in vivo (Lee et al., 1963 ), cefoxitin appears to be excreted virtually unchanged in man (Sonneville et al., 1973) . It should be pointed out that the cephalosporins which have more favourable pharmacokinetic features (such as cephanone) lack the wide and effective antimicrobial activity of cefoxitin (Meyers et al., 1972; Neu and Winshell, 1973) .
Like cephalothin, cefoxitin was non-toxic. The neutropenia in a volunteer receiving cephalothin may or may not have been drug related.
In conclusion, the good pharmacokinetic properties of cefoxitin together with the lower M.I.C. for most Gramnegative organisms and lack of toxicity seem very promising. These findings are sufficiently encouraging to justify clinical trials in order to define its place in chemotherapy.
